Lanean...
Dantrolene : From Malignant Hyperthermia to Alzheimer’s Disease
BACKGROUND & OBJECTIVE: Dantrolene, a ryanodine receptor antagonist, is primarily known as the only clinically acceptable and effective treatment for malignant hyperthermia (MH). Inhibition of ryanodine receptor (RyR) by dantrolene decreases the abnormal calcium release from the sarcoplasmic ret...
Gorde:
| Argitaratua izan da: | CNS Neurol Disord Drug Targets |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754833/ https://ncbi.nlm.nih.gov/pubmed/29921212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871527317666180619162649 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|